INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON EXERCISE PERFORMANCE AND CLINICAL SYMPTOMS IN CHRONIC HEART-FAILURE - A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引:17
|
作者
DOSSEGGER, L
ALDOR, E
BAIRD, MG
BRAUN, S
CLELAND, JGF
DONALDSON, R
JANSEN, LJ
JOY, MD
MARINNETO, JA
NOGUEIRA, E
STAHNKE, PL
STORM, T
机构
[1] F HOFFMANN LA ROCHE & CO LTD,DIV CARDIOVASC,CH-4002 BASEL,SWITZERLAND
[2] HANUSCH HOSP,VIENNA,AUSTRIA
[3] UNIV OTTAWA,INST HEART,OTTAWA K1N 6N5,ONTARIO,CANADA
[4] ICHILOV HOSP,IL-64239 TEL AVIV,ISRAEL
[5] HAMMERSMITH HOSP,CARDIOL UNIT,LONDON W12 0HS,ENGLAND
[6] NATL HEART HOSP,LONDON W1M 8BA,ENGLAND
[7] BOVENIJ ZIEKENHUIS,AMSTERDAM,NETHERLANDS
[8] ST PETERS HOSP,CHERTSEY KT16 0PZ,SURREY,ENGLAND
[9] FAC MED RIBEIRAO PRETO,HOSP CLIN,RIBEIRAO PRE,BRAZIL
[10] CID UNIV ZEFERINO VAZ,HOSP CLIN,CAMPINAS,BRAZIL
[11] PRAXIS SCHAEFERKAMPALLEE,HAMBURG,GERMANY
[12] SUNDBY HOSP,COPENHAGEN,DENMARK
关键词
CILAZAPRIL; CHRONIC HEART FAILURE; EXERCISE TOLERANCE;
D O I
10.1093/eurheartj/14.suppl_C.18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:18 / 23
页数:6
相关论文
共 50 条
  • [11] EFFECT OF CHRONIC ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON ENDOTHELIAL FUNCTION IN PATIENTS WITH CHRONIC HEART-FAILURE
    DREXLER, H
    KURZ, S
    JESERICH, M
    MUNZEL, T
    HORNIG, B
    AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (15): : E13 - E18
  • [12] RENAL EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE HEART-FAILURE
    GOTTLIEB, SS
    WEIR, MR
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (11): : D14 - D21
  • [13] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND PHYSICAL-TRAINING IN HEART-FAILURE
    MEYER, TE
    CASADEI, B
    COATS, AJS
    DAVEY, PP
    ADAMOPOULOS, S
    RADAELLI, A
    CONWAY, J
    JOURNAL OF INTERNAL MEDICINE, 1991, 230 (05) : 407 - 413
  • [14] CONTRASTING PERIPHERAL SHORT-TERM AND LONG-TERM EFFECTS OF CONVERTING ENZYME-INHIBITION IN PATIENTS WITH CONGESTIVE HEART-FAILURE - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DREXLER, H
    BANHARDT, U
    MEINERTZ, T
    WOLLSCHLAGER, H
    LEHMANN, M
    JUST, H
    CIRCULATION, 1989, 79 (03) : 491 - 502
  • [15] PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF PRAZOSIN IN CONGESTIVE HEART-FAILURE
    CRICK, W
    MEHTA, J
    MILES, D
    LIBERTY, S
    WELDON, S
    CARROLL, RG
    CONTI, CR
    CHRISTIE, LG
    CLINICAL RESEARCH, 1980, 28 (05): : A807 - A807
  • [16] ENALAPRIL IN CHRONIC HEART-FAILURE - A DOUBLE-BLIND PLACEBO CONTROLLED TRIAL
    SHARPE, N
    MURPHY, J
    COXON, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (02) : 471 - 471
  • [17] ENALAPRIL IN CHRONIC HEART-FAILURE, A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    REMES, J
    NIKANDER, P
    REHNBERG, S
    HALINEN, MO
    KUIKKA, J
    LANSIMIES, E
    PYORALA, K
    ANNALS OF CLINICAL RESEARCH, 1986, 18 (03): : 124 - 128
  • [18] EFFECT ON THE MYOCARDIAL ENERGY-METABOLISM OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CHRONIC HEART-FAILURE
    SCHULTHEISS, HP
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (14): : G74 - G81
  • [19] RENAL HEMODYNAMIC CONSEQUENCES OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE HEART-FAILURE
    SUKI, WN
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (03) : 669 - 673
  • [20] WHEN AND HOW TO USE ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IN CONGESTIVE HEART-FAILURE
    RYDEN, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (02): : A75 - A80